COMPARATIVE EFFECTIVENESS OF FIXED-DOSE FLUTICASONE PROPIONATE/SALMETEROL AND BUDESONIDE/FORMOTEROL COMBINATIONS IN ASTHMA: A US DATABASE ANALYSIS

被引：0
|
作者：
Hamouda, Mohamed
Hanania, Nicola A.
Stanford, Richard H.
Rendon, Adrian
Gemicioglu, Bilun
Fritscher, Leandro
Boonsawat, Watchara
Khan, Shireen Quli
机构：
来源：
CHEST | 2024年 / 166卷 / 04期
关键词：
D O I：
10.1016/j.chest.2024.07.075
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
引用
收藏
页码：6461A / 6462A
页数：2
相关论文
共 50 条
  • [41] Cost Effectiveness of Budesonide/Formoterol for Maintenance and Reliever Therapy versus Salmeterol/ Fluticasone plus Salbutamol in the Treatment of Asthma
    Gunnar Johansson
    Emma B. Andreasson
    Per E. Larsson
    Claus F. Vogelmeier
    PharmacoEconomics, 2006, 24 : 695 - 708
  • [42] Cost effectiveness of budesonide/formoterol for maintenance and reliever therapy versus salmeterol/fluticasone plus salbutamol in the treatment of asthma
    Johansson, Gunnar
    Andreasson, Emma B.
    Larsson, Per E.
    Vogelmeier, Claus F.
    PHARMACOECONOMICS, 2006, 24 (07) : 695 - 708
  • [43] Association between adherence with fixed dose combination fluticasone propionate/salmeterol on asthma outcomes and costs
    Delea, Thomas E.
    Stanford, Richard H.
    Hagiwara, May
    Stempel, David A.
    CURRENT MEDICAL RESEARCH AND OPINION, 2008, 24 (12) : 3435 - 3442
  • [44] Step-down compared to fixed-dose treatment with inhaled fluticasone propionate in asthma
    Foresi, A
    Mastropasqua, B
    Chetta, AF
    D'Ippolito, R
    Testi, R
    Olivieri, D
    Pelucchi, A
    CHEST, 2005, 127 (01) : 117 - 124
  • [45] Comparative effectiveness of budesonide/formoterol combination and fluticasone/salmeterol combination among chronic obstructive pulmonary disease patients new to controller treatment: a US administrative claims database study
    Kern, David M.
    Davis, Jill
    Williams, Setareh A.
    Tunceli, Ozgur
    Wu, Bingcao
    Hollis, Sally
    Strange, Charlie
    Trudo, Frank
    RESPIRATORY RESEARCH, 2015, 16
  • [46] Comparative effectiveness of budesonide/formoterol combination and fluticasone/salmeterol combination among chronic obstructive pulmonary disease patients new to controller treatment: a US administrative claims database study
    David M Kern
    Jill Davis
    Setareh A Williams
    Ozgur Tunceli
    Bingcao Wu
    Sally Hollis
    Charlie Strange
    Frank Trudo
    Respiratory Research, 16
  • [47] An evaluation of comparative treatment effects with high and low dose fluticasone propionate/formoterol combination in asthma
    Dissanayake, Sanjeeva
    Jain, Meena
    Grothe, Birgit
    McIver, Tammy
    Papi, Alberto
    PULMONARY PHARMACOLOGY & THERAPEUTICS, 2015, 35 : 19 - 27
  • [48] Retrospective Claims Study of Fluticasone Propionate/Salmeterol Fixed-Dose Combination Use as Initial Asthma Controller Therapy in Children Despite Guideline Recommendations
    Friedman, Howard S.
    Eid, Nemr S.
    Crespi, Simone
    Wilcox, Teresa K.
    Reardon, Gregory
    CLINICAL THERAPEUTICS, 2009, 31 (05) : 1056 - 1063
  • [49] Effect of Adjustable-Dose (AD) Budesonide/Formoterol Pressurized Metered-Dose Inhaler (pMDI), Fixed-Dose (FD) Budesonide/Formoterol pMDI, and FD Fluticasone/Salmeterol Dry Powder Inhaler (DPI) on Predose FEF25-75%.
    Kim, K. T.
    Lanier, B. Q.
    Goldman, M.
    Martin, P.
    Zangrilli, J.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2009, 179
  • [50] The assessment of effectiveness, tolerance, and patient satisfaction with the use of a new fixed-dose combination product, containing salmeterol and fluticasone propionate, Salflumix Easyhaler® in the treatment of asthma in the daily clinical practice
    Doniec, Zbigniew
    Olszanecka-Glinianowicz, Magdalena
    Hantulik, Piotr
    Almgren-Rachtan, Agnieszka
    Chudek, Jerzy
    JOURNAL OF ASTHMA, 2023, 60 (04) : 754 - 760
12345